Smallridge R C, Gist I D
Department of Clinical Physiology, Walter Reed Army Institute of Research, Washington, District of Columbia 20307-5100.
Am J Physiol. 1994 Aug;267(2 Pt 1):E323-30. doi: 10.1152/ajpendo.1994.267.2.E323.
Extracellular ATP increases inositol phosphates, cytosolic Ca2+ concentration ([Ca2+]i), arachidonic acid (AA) release, and iodide efflux in FRTL-5 cells. To examine the sequence of events in P2-purinergic receptor activation by ATP, a phospholipase C (PLC) inhibitor (U-73122) and a phospholipase A2 (PLA2) inhibitor (U-26384), as well as 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'- tetraacetic acid (BAPTA) and downregulation of protein kinase C (PKC) were used. ATP increased inositol trisphosphate (IP3), [Ca2+]i, AA release, and 125I efflux dose dependently. U-73122 inhibited the IP3 and calcium increase but not AA; U-26384 prevented AA release but not the increase in calcium. Both agents inhibited iodide efflux. BAPTA prevented any ATP-induced increase in [Ca2+]i without affecting AA release or 125I efflux. PKC downregulation had no effect on ATP-stimulated AA release, but reduced 125I efflux. We conclude that ATP-induced iodide efflux involves parallel, not sequential, activation of PLC and PLA2. No increase in [Ca2+]i or PKC activity is required for PLA2 activation. In contrast, an increase in 125I efflux depends on PKC and PLA2 activities, but not an increase in [Ca2+]i.
细胞外ATP可增加FRTL-5细胞中的肌醇磷酸、胞质Ca2+浓度([Ca2+]i)、花生四烯酸(AA)释放以及碘外流。为了研究ATP激活P2-嘌呤能受体的事件顺序,使用了磷脂酶C(PLC)抑制剂(U-73122)和磷脂酶A2(PLA2)抑制剂(U-26384),以及1,2-双(2-氨基苯氧基)乙烷-N,N,N',N'-四乙酸(BAPTA)和蛋白激酶C(PKC)的下调。ATP剂量依赖性地增加了三磷酸肌醇(IP3)、[Ca2+]i、AA释放和125I外流。U-73122抑制了IP3和钙的增加,但不抑制AA;U-26384阻止了AA释放,但不阻止钙的增加。两种药物均抑制碘外流。BAPTA阻止了ATP诱导的[Ca2+]i增加,而不影响AA释放或125I外流。PKC下调对ATP刺激的AA释放没有影响,但减少了125I外流。我们得出结论,ATP诱导的碘外流涉及PLC和PLA2的平行激活,而非顺序激活。PLA2激活不需要[Ca2+]i或PKC活性增加。相反,125I外流的增加取决于PKC和PLA2的活性,但不取决于[Ca2+]i的增加。